ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Hematologic Cancer
Recurrence

Acute Myeloid Leukemia (AML) trials near Miami, FL, USA:

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...

Enrolling
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)
Drug: CLN-049

Phase 1

Cullinan Therapeutics Inc.

Miami, Florida, United States and 10 other locations

to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...

Enrolling
Relapsed Adult AML
Leukemia, Myeloid, Acute
Drug: Venetoclax Oral Tablet
Drug: Tuspetinib

Phase 1, Phase 2

Aptose Biosciences

Miami, Florida, United States and 33 other locations

People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML hav...

Enrolling
Acute Myeloid Leukemia (AML)
FLT3-mutated Acute Myeloid Leukemia
Drug: Azacitidine
Drug: Venetoclax

Phase 1, Phase 2

Astellas
Astellas

Pembroke Pines, Florida, United States and 19 other locations

Anti-tumor Activity of LYT- 200 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), or with Relaps...

Enrolling
AML, Adult Recurrent
MDS
Drug: Azacitidine
Drug: Decitabine

Phase 1

PureTech Health

Miami, Florida, United States and 10 other locations

study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 1

Aptevo Therapeutics

Miami, Florida, United States and 6 other locations

subjects with previously treated or untreated with high risk factor acute myeloid leukemia (AML). Venetoclax and ...

Active, not recruiting
Acute Myeloid Leukemia, Adult
Drug: ADI-PEG 20

Phase 1

Polaris Group

Miami, Florida, United States and 3 other locations

in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Decitabine and Cedazuridine (ASTX727)
Drug: Venetoclax

Phase 1, Phase 2

Taiho Pharma
Taiho Pharma

Plantation, Florida, United States and 33 other locations

). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....

Enrolling
Acute Myeloid Leukemia
Drug: Tagraxofusp
Drug: Azacitidine

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Miami, Florida, United States and 32 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Weston, Florida, United States and 193 other locations

participants with AML.The duration of this multi-phase study is approximately 7 years....

Enrolling
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Drug: Venetoclax
Drug: ASTX030 (cedazuridine + azacitidine)

Phase 2, Phase 3

Taiho Pharma
Taiho Pharma

Miami, Florida, United States and 71 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems